Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Blood
|
September 8, 2025
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma
Lorenzo Falchi, Anna Sureda, Sirpa Leppä, et al.
Haematologica
|
March 5, 2026
Epcoritamab plus rituximab, dexamethasone, cytarabine, oxaliplatin/carboplatin induces deep and durable responses in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma: results from the EPCORE NHL-2 trial
Pau Abrisqueta, Yasmin H Karimi, Daniel Morillo, et al.
Cancers
|
March 29, 2023
Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting
Serena Zheng, Kanika Gupta, Piyush Goyal, et al.
Blood Advances
|
July 30, 2020
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
David Sermer, Sabela Bobillo, Ahmet Dogan, et al.
Leukemia & Lymphoma
|
July 2, 2025
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis
Efrat Luttwak, Edith Tama Robin, Esther Drill, et al.
Haematologica
|
November 27, 2025
Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma
Erel Joffe, Manik Uppal, Serena Zheng, et al.
Cancer Cytopathology
|
December 27, 2022
Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collaborative study
Megan J Fitzpatrick, Vandana Sundaram, Amy Ly, et al.
Blood Cancer Journal
|
July 2, 2025
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan, et al.
Leukemia & Lymphoma
|
June 28, 2021
Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation
Eric Mou, Lorenzo Falchi, Vandana Sundaram, et al.
Blood
|
September 1, 2019
Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study
Owen A O'Connor, Lorenzo Falchi, Jennifer K Lue, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Blood
|
September 8, 2025
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma
Lorenzo Falchi, Anna Sureda, Sirpa Leppä, et al.
Haematologica
|
March 5, 2026
Epcoritamab plus rituximab, dexamethasone, cytarabine, oxaliplatin/carboplatin induces deep and durable responses in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma: results from the EPCORE NHL-2 trial
Pau Abrisqueta, Yasmin H Karimi, Daniel Morillo, et al.
Cancers
|
March 29, 2023
Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting
Serena Zheng, Kanika Gupta, Piyush Goyal, et al.
Blood Advances
|
July 30, 2020
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
David Sermer, Sabela Bobillo, Ahmet Dogan, et al.
Leukemia & Lymphoma
|
July 2, 2025
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis
Efrat Luttwak, Edith Tama Robin, Esther Drill, et al.
Haematologica
|
November 27, 2025
Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma
Erel Joffe, Manik Uppal, Serena Zheng, et al.
Cancer Cytopathology
|
December 27, 2022
Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto-Heme Interinstitutional Collaborative study
Megan J Fitzpatrick, Vandana Sundaram, Amy Ly, et al.
Blood Cancer Journal
|
July 2, 2025
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan, et al.
Leukemia & Lymphoma
|
June 28, 2021
Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation
Eric Mou, Lorenzo Falchi, Vandana Sundaram, et al.
Blood
|
September 1, 2019
Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study
Owen A O'Connor, Lorenzo Falchi, Jennifer K Lue, et al.
Page
of 8